Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition

Chemical inhibition of the CBFβ/RUNX interaction is a viable strategy for the treatment of ovarian cancer.